Secondary prevention of preeclampsia
Preventing preeclampsia (PE) is crucial for the wellbeing of the mother, fetus, and the neonate with three levels: primary, secondary, and tertiary. Secondary prevention involves pharmacological therapies aimed at stopping the disease’s progression before clinical signs. The predominant approach cur...
Saved in:
Main Authors: | Muhammad Ilham Aldika Akbar, Roudhona Rosaudyn, Khanisyah Erza Gumilar, Renuka Shanmugalingam, Gustaaf Dekker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1520218/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The promise and challenges of Artificial Intelligence-Large Language Models (AI-LLMs) in obstetric and gynecology
by: Khanisyah Erza Gumilar, et al.
Published: (2024-07-01) -
Current preeclampsia prediction model and biomarker
by: Anak Agung Ngurah Jaya Kusuma
Published: (2024-11-01) -
Elevated Liver Function Tests as Predictors of Severe Maternal Outcomes in Women with Preeclampsia
by: Sadia Chaudhary, et al.
Published: (2025-01-01) -
Maternal Serum Uric Acid as an Index of Perinatal Outcomes in Severe Preeclampsia
by: Rozhan Yassin Khalil, et al.
Published: (2018-07-01) -
The use of N-acetylcysteine to prevent further progression of preeclampsia
by: I Wayan Agung Indrawan, et al.
Published: (2024-07-01)